课题基金 / 基金详情

Molecular pathogenesis of BRCA1-associated and triple-negative breast cancer: mechanism of tissue specificity and identification and characterization of cooperating tumorigenic pathways.

Molecular pathogenesis of BRCA1-associated and triple-negative breast cancer: mechanism of tissue specificity and identification and characterization of cooperating tumorigenic pathways.
BRCA1 相关和三阴性乳腺癌的分子发病机制：组织特异性机制以及协同致瘤途径的识别和表征。
批准号：
206486
负责人：
Cescon David W
金额：
$1.46万
依托单位：
University of Toronto
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2009
资助国家：
加拿大
项目状态：
已结题
起止时间：
2009-10-01 至 2013-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=206486&lang=en
关键词：
Animal Models Of Cancer Brca1 Associated Cancer Cancer Medical Oncology Oncogenes And Tumor Suppressor Genes Rnai

项目摘要

项目成果

Cescon David W的其他基金

相关文献

中文摘要
翻译
乳腺癌每年影响近23000名加拿大妇女，并且仍然是主要的死亡原因。5%的乳腺癌和80%的遗传病例是由BRCA1基因突变引起的。携带这些突变的女性也有很高的风险。
英文摘要
Breast cancer affects almost 23 000 Canadian women each year, and remains a major cause of death. Five percent all breast cancers, and 80% of inherited cases, are caused by mutations in the BRCA1 gene. Women who carry these mutations are also at high risk
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery and validation of vulnerabilities and therapeutic strategies for cyclin-dependent kinase 4/6 inhibitor-resistant hormone receptor positive breast cancer
  • 批准号：
    435434
  • 项目类别：
    Operating Grants
  • 资助金额：
    $65.2万
  • 财政年份：
    2020
  • 负责人：
    Cescon David W
  • 依托单位：
    University Health Network (Toronto)
Molecular pathogenesis of BRCA1-associated and triple-negative breast cancer: mechanism of tissue specificity and identification and characterization of cooperating tumorigenic pathways.
  • 批准号：
    194162
  • 项目类别：
    Fellowship Programs
  • 资助金额：
    $8.74万
  • 财政年份：
    2009
  • 负责人：
    Cescon David W
  • 依托单位：
    University of Toronto